| scholarly article | Q13442814 |
| P2093 | author name string | Alan S Maisel | |
| Elizabeth Lee | |||
| Saloni Shah | |||
| Hermineh Aramin | |||
| Dipika Gopal | |||
| Rajiv Choudhary | |||
| Alejandro De La Parra Landa | |||
| Ben A Kipper | |||
| P2860 | cites work | Increased cardiac troponin T levels are related to inflammatory markers and various indices of renal function in chronic renal disease patients | Q83412682 |
| Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention | Q84193202 | ||
| Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group | Q21195082 | ||
| The lipocalin protein family: structure and function | Q24529878 | ||
| Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin | Q27621524 | ||
| Biomarkers in acute myocardial infarction. | Q33596823 | ||
| Co-peptin: Role as a novel biomarker in clinical practice | Q33710301 | ||
| Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative | Q33728260 | ||
| Molecular aspects and natural source of procalcitonin | Q33760702 | ||
| Procalcitonin for accurate detection of infection in haemodialysis | Q73819981 | ||
| National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes | Q80032866 | ||
| Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography | Q80739474 | ||
| NGAL is an early predictive biomarker of contrast-induced nephropathy in children | Q81305644 | ||
| Modulation and source of procalcitonin in reduced renal function and renal replacement therapy | Q81345099 | ||
| Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure | Q33799444 | ||
| Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury | Q33830710 | ||
| Acute heart failure registry from high-volume university hospital ED: comparing European and US data | Q33922743 | ||
| Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. | Q34005206 | ||
| Copeptin: clinical use of a new biomarker | Q34010057 | ||
| Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. | Q34026975 | ||
| In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study. | Q34027034 | ||
| The utility of troponin measurement to detect myocardial infarction: review of the current findings. | Q34139055 | ||
| The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies | Q34179896 | ||
| Cystatin C as a marker of acute kidney injury in the emergency department | Q34281311 | ||
| Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. | Q34306146 | ||
| The cardiorenal syndrome: making the connection | Q34340391 | ||
| Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath | Q34347905 | ||
| Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure | Q34566520 | ||
| Dual action of neutrophil gelatinase-associated lipocalin | Q34603152 | ||
| Procalcitonin as a marker of sepsis | Q34750152 | ||
| Pathobiochemistry and clinical use of procalcitonin | Q34756556 | ||
| Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients | Q34999108 | ||
| New biomarkers of acute kidney injury and the cardio-renal syndrome | Q35048051 | ||
| Adrenomedullin and heart failure | Q35095496 | ||
| Clinical applications of B-type natriuretic peptide (BNP) testing. | Q35548836 | ||
| Brain and other natriuretic peptides: molecular aspects | Q35677302 | ||
| Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial | Q35770965 | ||
| Serum high-sensitivity cardiac troponin T is a significant biomarker of left-ventricular diastolic dysfunction in subjects with non-diabetic chronic kidney disease. | Q35791735 | ||
| Neurohormonal activation in congestive heart failure and the role of vasopressin | Q36104992 | ||
| Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study | Q36465429 | ||
| Renal impairment and outcomes in heart failure: systematic review and meta-analysis | Q36477172 | ||
| Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. | Q36574151 | ||
| Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. | Q36576780 | ||
| Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy | Q36814875 | ||
| Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators | Q36927312 | ||
| The pathophysiology of acute heart failure--is it all about fluid accumulation? | Q37033048 | ||
| Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease | Q37196895 | ||
| Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. | Q37251326 | ||
| State of the art: using natriuretic peptide levels in clinical practice | Q37257460 | ||
| Cardiorenal syndrome | Q37324890 | ||
| From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. | Q37736542 | ||
| The stress hormone copeptin: a new prognostic biomarker in acute illness | Q37792919 | ||
| Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis | Q37878032 | ||
| Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment | Q37900203 | ||
| Novel biomarkers in diagnosing cardiac ischemia in the emergency department: a systematic review. | Q37971437 | ||
| Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study | Q38487799 | ||
| Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease | Q39774954 | ||
| Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. | Q39828831 | ||
| Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort | Q39936653 | ||
| Gender and renal function influence plasma levels of copeptin in healthy individuals | Q40067883 | ||
| Natriuretic peptide levels: what's on the horizon? | Q40119206 | ||
| Quality of care for elderly patients hospitalized with heart failure | Q41620458 | ||
| Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells | Q42488265 | ||
| Impact of Worsening Renal Function During Hospital Admission on Resource Utilization in Patients With Heart Failure | Q42870341 | ||
| Improving risk stratification in heart failure: a role for new biomarkers? | Q43119693 | ||
| Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure | Q43136870 | ||
| Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure | Q43413217 | ||
| C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction | Q43795750 | ||
| Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults | Q43907202 | ||
| Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. | Q44112363 | ||
| Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma | Q44233195 | ||
| Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction | Q44450408 | ||
| Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ. | Q45008043 | ||
| Evaluation of neurohumoral activation (adrenomedullin, BNP, catecholamines, etc.) in patients with acute myocardial infarction | Q45194540 | ||
| Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. | Q45929238 | ||
| C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study | Q46061278 | ||
| The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. | Q46064586 | ||
| Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study | Q46180047 | ||
| Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure | Q46356815 | ||
| Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery | Q46423060 | ||
| Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). | Q46480414 | ||
| Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. | Q46753402 | ||
| Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin | Q46790418 | ||
| Kidney NGAL is a novel early marker of acute injury following transplantation | Q46984063 | ||
| Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study | Q48132900 | ||
| Cardiac troponin T vs other biochemical markers in patients with congestive heart failure | Q48189653 | ||
| Amino-terminal pro-brain natriuretic Peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? | Q48395509 | ||
| Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study | Q48680598 | ||
| NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study | Q48692181 | ||
| Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. | Q51181204 | ||
| Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. | Q53063241 | ||
| Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure. | Q53090641 | ||
| Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. | Q53147437 | ||
| Cardiorenal syndromes | Q61661128 | ||
| Techniques used in the measurement of body composition: an overview with emphasis on bioelectrical impedance analysis | Q71465652 | ||
| High serum procalcitonin concentrations in patients with sepsis and infection | Q72211281 | ||
| Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro | Q73524167 | ||
| P433 | issue | 3 | |
| P921 | main subject | heart failure | Q181754 |
| biomarker | Q864574 | ||
| acute decompensated heart failure | Q4677930 | ||
| P304 | page(s) | 292-304 | |
| P577 | publication date | 2012-09-01 | |
| P1433 | published in | Journal of Geriatric Cardiology | Q15765238 |
| P1476 | title | Cardiorenal biomarkers in acute heart failure | |
| P478 | volume | 9 |
| Q28084462 | Evaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistances |
| Q50077377 | Evaluation of serum neutrophil gelatinase-associated lipocalin as a novel biomarker of cardiorenal syndrome in dogs |
| Q38187750 | Heart failure biomarkers at point-of-care: current utilization and future potential |
| Q57824569 | Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure: remaining issues and challenges |
| Q35903093 | Urinary Angiotensinogen Level Predicts AKI in Acute Decompensated Heart Failure: A Prospective, Two-Stage Study |
Search more.